These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2650312)

  • 21. Persisting acute rejection in heart transplantation: ciclosporin and azathioprine therapy.
    Dubois C; Schlumberger S; Brodaty D; Goudot B; Bachet J; Guilmet D
    Bibl Cardiol; 1988; (43):33-4. PubMed ID: 3067719
    [No Abstract]   [Full Text] [Related]  

  • 22. A limited sampling strategy for the measurement of cyclosporine AUC.
    Johnston A; Sketris I; Marsden JT; Galustian CG; Fashola T; Taube D; Pepper J; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1345-6. PubMed ID: 2349694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunosuppression and the problems in partial liver transplantation].
    Kawasaki M; Hashikura Y; Matsunami H; Makunouchi M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):683. PubMed ID: 8963785
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 25. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
    [No Abstract]   [Full Text] [Related]  

  • 26. Short-term boost of oral steroids for treatment of acute rejection following cardiac transplantation.
    Wahlers T; Cremer J; Fieguth HG; Jurmann M; Herrmann G; Schäfers HJ; Haverich A; Kemnitz J; Borst HG
    Bibl Cardiol; 1988; (43):19-22. PubMed ID: 3067717
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 28. Quality assessment of cyclosporine monitoring--Canadian validations.
    Wong PY; Mee AV; Glenn J; Keown PA
    Transplant Proc; 1990 Jun; 22(3):1216-7. PubMed ID: 2349683
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of moderate heart allograft rejection with cyclosporine.
    Radovancevic B; Frazier OH
    J Heart Transplant; 1986; 5(4):307-11. PubMed ID: 3114444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
    Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
    J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Clardy CW; Pesce AJ; Wadhwa NK; Collins JA; Wolf RK; Brown LL; Stephens GW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):316-22. PubMed ID: 3291262
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological study of cyclosporine in heterotopic transplantation of canine hearts.
    Suzuki S; Mizuochi I; Amemiya H
    Transplantation; 1985 May; 39(5):565-8. PubMed ID: 3158109
    [No Abstract]   [Full Text] [Related]  

  • 34. Performance of the Sandoz radioimmunoassays for cyclosporine.
    Holt DW; Marsden JT; Fashola TO; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of cardiac rejection in heart and heart-lung transplantation.
    Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
    J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
    Tolkoff-Rubin NE; Rubin RH
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple injections of KCl-extracted donor-antigen in combination with a short course of cyclosporine therapy induces prolonged heart allograft survival in rats.
    Goto S; Stepkowski SM; Kahan BD
    Transplant Proc; 1989 Apr; 21(2):3300-2. PubMed ID: 2652819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.